Rovi Pharmaceuticals Laboratories
Clinical trials sponsored by Rovi Pharmaceuticals Laboratories, explained in plain language.
-
New shot for breast cancer aims to match standard pill
Disease control Not yet recruitingThis study aims to see if a new injectable form of the hormone therapy letrozole works as well and is as safe as the standard pill version. Both are given alongside another cancer drug called palbociclib. It will involve 300 postmenopausal women with a specific type of advanced b…
Phase: PHASE3 • Sponsor: Rovi Pharmaceuticals Laboratories • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Quarterly shot could replace daily breast cancer pills
Disease control Not yet recruitingThis study is testing a new quarterly injection of the hormone therapy drug letrozole to see if it gets into the bloodstream as well as the standard daily pill. It will involve 120 post-menopausal women who have already been treated for early-stage, hormone-positive breast cancer…
Phase: PHASE1 • Sponsor: Rovi Pharmaceuticals Laboratories • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC